迪哲医药-U
(688192)
| 流通市值：77.65亿 | | | 总市值：173.70亿 |
| 流通股本：1.87亿 | | | 总股本：4.18亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 130,831,963.06 | 102,845,764.96 | 95,312,852.54 | 74,201,573.96 |
| 应收票据及应收账款 | 80,917,263.2 | 93,704,233 | 44,131,815 | 48,040,333.77 |
| 应收账款 | 80,917,263.2 | 93,704,233 | 44,131,815 | 48,040,333.77 |
| 预付款项 | 31,984,515.32 | 38,118,348.28 | 49,810,954.8 | 53,142,591.08 |
| 其他应收款合计 | 3,634,102.13 | 3,619,677.8 | 3,404,754.13 | 3,370,300.9 |
| 存货 | 34,626,457.01 | 32,611,990.93 | 33,444,320.21 | 23,470,661.27 |
| 其他流动资产 | 17,461,163.22 | 25,995,614.37 | 31,226,876.97 | 34,137,629.49 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 976,922,487.65 | 1,021,982,600.85 | 978,932,665.1 | 910,361,387.23 |
| 非流动资产: | | | | |
| 固定资产 | 20,660,331.68 | 21,248,727.32 | 22,654,904.05 | 22,095,817.03 |
| 在建工程 | 105,753,565.7 | 76,514,941.67 | 17,846,629.35 | 13,347,166.35 |
| 使用权资产 | 62,195,451.44 | 54,519,033.38 | 60,666,515.12 | 66,813,996.86 |
| 无形资产 | 437,860,297.35 | 446,285,532.41 | 454,185,792.1 | 461,979,190.5 |
| 长期待摊费用 | 10,686,598.19 | 12,839,424.91 | 15,099,564.54 | 16,986,644.25 |
| 其他非流动资产 | 28,430,325.57 | 11,579,384.91 | 2,852,188.73 | 4,794,365.22 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 665,586,569.93 | 622,987,044.6 | 573,305,593.89 | 586,017,180.21 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,642,509,057.58 | 1,644,969,645.45 | 1,552,238,258.99 | 1,496,378,567.44 |
| 流动负债: | | | | |
| 短期借款 | 235,184,441.1 | 203,075,562.56 | 264,550,678.88 | 200,114,966.97 |
| 应付票据及应付账款 | 127,226,939.21 | 157,812,729.88 | 159,544,478.09 | 108,932,147.81 |
| 应付账款 | 127,226,939.21 | 157,812,729.88 | 159,544,478.09 | 108,932,147.81 |
| 合同负债 | 2,665,900 | 1,921,980 | 1,541,600 | 981,760 |
| 应付职工薪酬 | 75,862,206.9 | 59,537,051.21 | 36,701,975.35 | 55,957,058.75 |
| 应交税费 | 7,429,488.15 | 6,438,773.39 | 11,483,017.77 | 12,435,727.5 |
| 其他应付款合计 | 73,926,693.07 | 96,974,355.2 | 51,831,626.66 | 46,965,759.15 |
| 一年内到期的非流动负债 | 44,605,234.63 | 20,319,513.57 | 19,056,441.86 | 23,048,164.79 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 566,900,903.06 | 546,079,965.81 | 544,709,818.61 | 448,435,584.97 |
| 非流动负债: | | | | |
| 长期借款 | 584,395,297.38 | 423,665,332.54 | 256,873,746.11 | 138,313,291.49 |
| 租赁负债 | 39,763,903.1 | 39,152,427.82 | 42,667,813.68 | 48,894,490.52 |
| 递延收益 | 14,202,087.44 | 14,560,848.8 | 11,394,214.22 | 12,107,784.66 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 638,361,287.92 | 477,378,609.16 | 310,935,774.01 | 199,315,566.67 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,205,262,190.98 | 1,023,458,574.97 | 855,645,592.62 | 647,751,151.64 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 415,653,120 | 415,653,120 | 415,653,120 | 408,151,370 |
| 资本公积 | 3,084,806,061.63 | 3,051,720,994.13 | 3,018,739,304.21 | 2,954,040,912.77 |
| 未分配利润 | -3,072,025,396.91 | -2,858,315,754.74 | -2,737,799,757.84 | -2,513,564,866.97 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 428,433,784.72 | 609,058,359.39 | 696,592,666.37 | 848,627,415.8 |
| 少数股东权益 | 8,813,081.88 | 12,452,711.09 | - | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 437,246,866.6 | 621,511,070.48 | 696,592,666.37 | 848,627,415.8 |
| 负债和股东权益合计 | 1,642,509,057.58 | 1,644,969,645.45 | 1,552,238,258.99 | 1,496,378,567.44 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |